Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)
Clinical trial NCT01550367 · COMPLETED
Trial details
- NCT number
- NCT01550367
- Sponsor
- Leonard Appleman
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2018-02-06
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.